	应收帐款人		日
Alaunos Therapeutics	USD 2K	0	2025-06
Amgen	USD 9.14B	432M	2026-03
AstraZeneca	USD 17.88B	1.17B	2026-03
Baxter International	USD 1.7B	310M	2026-03
Biogen	USD 1.79B	76.6M	2026-03
Bioline Rx	USD 699K	418K	2025-09
Bristol-Myers Squibb	USD 14.36B	164M	2026-03
Celltrion	KRW 2.05T	542.39B	2025-12
Corcept Therapeutics	USD 39.07M	20.71M	2026-03
Cspc Pharmaceutical	CNY 8.79B	64.64M	2025-12
Curis	USD 2.55M	400K	2024-06
Deva Holding AS	TRY 3.03B	343.23M	2023-09
Dianthus Therapeutics	USD 52K	4.95M	2025-12
Divis Laboratories Ltd	INR 29.99B	3.71B	2026-03
Gilead Sciences	USD 4.74B	172M	2026-03
GlaxoSmithKline	GBP 7.94B	178M	2026-03
Incyte	USD 1.05B	27.09M	2026-03
Intrexon	USD 1.02M	559K	2024-06
Ionis Pharmaceuticals	USD 74M	8M	2026-03
J&J	USD 21.33B	3.72B	2025-12
Kangmei Pharma	CNY 2.92B	228.09M	2026-03
Karyopharm Therapeutics	USD 26.18M	5.6M	2025-12
Knight Therapeutics	CAD 183M	7.46M	2025-12
Laboratorios Farma	EUR 143.38M	16.93M	2023-12
Malin Corporation	EUR 500K	300K	2024-12
Medical Developments International	AUD 7.48M	174K	2025-12
Merck	USD 11.78B	345M	2025-12
Neuren Pharmaceuticals	AUD 26.54M	5.83M	2025-12
Novartis	USD 9.6B	2.69B	2026-03
Organigram Holdings	CAD 49.94M	14.92M	2025-12
Ovoca Bio	EUR 39K	408K	2025-06
Pfizer	USD 16.17B	332M	2026-03
Pharma Mar	EUR 51.19M	9.4M	2026-03
PTC Therapeutics	USD 181.62M	21.45M	2025-12
Qiagen NV	USD 402.61M	9.05M	2025-12
Regeneron Pharmaceuticals	USD 5.73B	10.1M	2026-03
Roche Holding	CHF 11.9B	460M	2025-12
Sangamo BioSciences	USD 581K	110K	2024-06
Sartorius	EUR 366.6M	74.9M	2026-03
Sino Biopharmaceutical	CNY 8.45B	3.18B	2025-06
TG Therapeutics	USD 392.05M	86.42M	2026-03
Tilray	USD 109.07M	2M	2025-09
Verastem	USD 9.01M	8.81M	2025-12
Zealand Pharma A/S	340M	94.1M	2025-12
Zz Pientze Pharmaceu	CNY 1.06B	60.42M	2026-03